Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transformation Plans

NEXT STORY
BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of Directors
PREV STORY
Akoya Biosciences Announces Founding Members of First-of-its-Kind Imaging Innovators (I²) Network
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rafael Pharmaceuticals to Present Plan for Phase 3 Trial (AVENGER 500) of devimistat (CPI-613®) in Combination with Modified FOLFIRINOX as a First Line Treatment for Metastatic Pancreatic Cancer at 2019 Gastrointestinal Cancers Symposium

Newark, NJ, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in ...

author_avatar
NASDAQ Market News

The North America organoids market is expected to reach US$ 1,406.47 million by 2027 from US$ 291.39 million in 2019

author_avatar
NASDAQ Market News

Virtual Clinical Trial Service Providers Market by Type of Therapeutic Area, End-Users, Phase of Development, and Key Geographies : Industry Trends and Global Forecasts, 2020-2050

author_avatar
NASDAQ Market News